Evofem Biosciences (EVFM) Total Liabilities (2014 - 2026)
Evofem Biosciences' Total Liabilities came in at $95.04 million for Q2 2026, up 13.1% from $84 million a year earlier and up 11.7% from the prior quarter.
Evofem Biosciences (EVFM) Total Liabilities (2014 - 2026) Analysis & Trends
At the end of FY2025, Evofem Biosciences' Total Liabilities was $94.61 million, down 0.5% from FY2024.
- Total Liabilities carries a five-year compound annual growth rate of -2.7% (FY2020 to FY2025).
- Going back by year, Total Liabilities was $95.05 million in FY2024 (+23.3%), $77.06 million in FY2023 (-20.5%), $96.96 million in FY2022 (-34.0%) and $146.83 million in FY2021 (+35.2%).
- The Q2 2026 figure represents the highest quarterly Total Liabilities since Q4 2024.
- Year-over-year, Total Liabilities increased in six of the last eight quarters, with growth averaging 10.2%.
- The fastest year-over-year change in Total Liabilities over five years came in Q2 2022 (growth of 170.1%), and the weakest in Q2 2023 (a decline of 74.1%).
- Business Quant data shows EVFM's Total Liabilities at $85.07 million (Q1 2026), $94.61 million (Q4 2025) and $88.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.71 Bn | 1,140.30 Bn | 19.71 Bn | 108.40 Bn |
| 2 | Johnson & Johnson | 642.13 Bn | 560.65 Bn | 17.26 Bn | 116.09 Bn |
| 3 | AbbVie | 501.64 Bn | 474.75 Bn | 12.70 Bn | 141.05 Bn |
| 4 | Merck | 375.66 Bn | 330.04 Bn | 12.21 Bn | 87.82 Bn |
| 5 | Novartis Ag | 302.79 Bn | 266.78 Bn | 11.24 Bn | 80.09 Bn |
| 6 | Astrazeneca | 268.68 Bn | 242.37 Bn | 12.86 Bn | 65.46 Bn |
| 7 | Amgen | 242.43 Bn | 197.83 Bn | 7.24 Bn | 83.95 Bn |
| 8 | Gilead Sciences | 193.69 Bn | 167.89 Bn | 6.22 Bn | 37.53 Bn |
| 9 | Pfizer | 172.47 Bn | 119.12 Bn | 10.94 Bn | 115.64 Bn |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | 95.04 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.04 Mn |
| Mar 31, 2026 | 85.07 Mn |
| Dec 31, 2025 | 94.61 Mn |
| Sep 30, 2025 | 88.87 Mn |
| Jun 30, 2025 | 84.00 Mn |
| Mar 31, 2025 | 82.46 Mn |
| Dec 31, 2024 | 95.05 Mn |
| Sep 30, 2024 | 94.83 Mn |
| Jun 30, 2024 | 77.87 Mn |
| Mar 31, 2024 | 78.88 Mn |
| Dec 31, 2023 | 77.06 Mn |
| Sep 30, 2023 | 69.68 Mn |
| Jun 30, 2023 | 69.74 Mn |
| Mar 31, 2023 | 82.44 Mn |
| Dec 31, 2022 | 96.96 Mn |
| Sep 30, 2022 | 120.33 Mn |
| Jun 30, 2022 | 269.47 Mn |
| Mar 31, 2022 | 162.67 Mn |
| Dec 31, 2021 | 146.83 Mn |
| Sep 30, 2021 | 126.25 Mn |
Evofem Biosciences Total Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-liabilities&ticker=EVFM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-liabilities", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-liabilities&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();